https://www.vjneurology.com/video/2qmqzh0hxbg-aso-tominersen-for-huntingtons-disease-in-phase-iii-trials/
ASO tominersen for Huntington’s disease in Phase III trials - VJNeurology
Sep 9, 2026 - Edward Wild, MA, MB BChir, FRCP, PhD, UCL Queen Square Institute of Neurology, London, UK, discusses the root cause of Huntington’s disease via the protein...
phase iii trialsasotominersendisease
https://pharmetheus.com/publications/quantitative-relationship-between-tominersen-concentrations-in-cerebrospinal-fluid-and-biomarker-changes-in-huntingtons-disease-patients
Quantitative Relationship Between Tominersen Concentrations in Cerebrospinal Fluid and Biomarker...
Explore recent publications by Pharmetheus affiliates, highlighting innovative research in pharmacokinetics, drug development, and regulatory strategies in the...
cerebrospinal fluidquantitativerelationshiptominersenconcentrations